Most patients diagnosed with glioblastoma die within a year, so innovative therapeutic strategies are needed. An editorial describes the science behind one strategy using a secreting chimeric antigen receptor (CAR) T cell. Read the full editorial:
Most patients diagnosed with glioblastoma die within a year, so innovative therapeutic strategies are needed. An editorial describes the science behind one strategy using a secreting chimeric antigen receptor (CAR) T cell. Read the full editorial:
Leave a reply